KR100795760B1 - 영장류 배아 줄기 세포의 무혈청 배양 - Google Patents
영장류 배아 줄기 세포의 무혈청 배양 Download PDFInfo
- Publication number
- KR100795760B1 KR100795760B1 KR1020027011681A KR20027011681A KR100795760B1 KR 100795760 B1 KR100795760 B1 KR 100795760B1 KR 1020027011681 A KR1020027011681 A KR 1020027011681A KR 20027011681 A KR20027011681 A KR 20027011681A KR 100795760 B1 KR100795760 B1 KR 100795760B1
- Authority
- KR
- South Korea
- Prior art keywords
- stem cells
- growth factor
- embryonic stem
- serum
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000001671 embryonic stem cell Anatomy 0.000 title claims abstract description 28
- 241000288906 Primates Species 0.000 title claims abstract description 25
- 210000002966 serum Anatomy 0.000 claims abstract description 49
- 210000004027 cell Anatomy 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 31
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims abstract description 18
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims abstract description 18
- 210000002950 fibroblast Anatomy 0.000 claims abstract description 18
- 241001465754 Metazoa Species 0.000 claims abstract description 17
- 229940126864 fibroblast growth factor Drugs 0.000 claims abstract description 17
- 238000012258 culturing Methods 0.000 claims abstract description 15
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 21
- 210000000130 stem cell Anatomy 0.000 claims description 12
- 210000003981 ectoderm Anatomy 0.000 claims description 5
- 210000001900 endoderm Anatomy 0.000 claims description 5
- 239000003102 growth factor Substances 0.000 claims description 5
- 210000003716 mesoderm Anatomy 0.000 claims description 5
- 101001052035 Homo sapiens Fibroblast growth factor 2 Proteins 0.000 claims description 4
- 230000001605 fetal effect Effects 0.000 claims description 4
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 3
- 230000019491 signal transduction Effects 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 abstract description 8
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 18
- 239000002609 medium Substances 0.000 description 12
- 238000010367 cloning Methods 0.000 description 11
- 230000006698 induction Effects 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 210000001654 germ layer Anatomy 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010043276 Teratoma Diseases 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 239000012679 serum free medium Substances 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 108091008794 FGF receptors Proteins 0.000 description 2
- 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 102100032352 Leukemia inhibitory factor Human genes 0.000 description 2
- 108090000581 Leukemia inhibitory factor Proteins 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000005945 translocation Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 1
- 102100031614 Ciliary neurotrophic factor Human genes 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102100020880 Kit ligand Human genes 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108010039445 Stem Cell Factor Proteins 0.000 description 1
- 206010043275 Teratogenicity Diseases 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 102000002070 Transferrins Human genes 0.000 description 1
- 108010015865 Transferrins Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000002459 blastocyst Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000010370 cell cloning Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 210000001728 clone cell Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 230000010311 mammalian development Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 102000035025 signaling receptors Human genes 0.000 description 1
- 108091005475 signaling receptors Proteins 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000211 teratogenicity Toxicity 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/522,030 | 2000-03-09 | ||
| US09/522,030 US7005252B1 (en) | 2000-03-09 | 2000-03-09 | Serum free cultivation of primate embryonic stem cells |
| PCT/US2001/006912 WO2001066697A2 (en) | 2000-03-09 | 2001-03-02 | Serum free cultivation of primate embryonic stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20030032926A KR20030032926A (ko) | 2003-04-26 |
| KR100795760B1 true KR100795760B1 (ko) | 2008-01-21 |
Family
ID=24079156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020027011681A Expired - Lifetime KR100795760B1 (ko) | 2000-03-09 | 2001-03-02 | 영장류 배아 줄기 세포의 무혈청 배양 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US7005252B1 (enExample) |
| EP (1) | EP1261691B1 (enExample) |
| JP (3) | JP5717311B2 (enExample) |
| KR (1) | KR100795760B1 (enExample) |
| CN (1) | CN100372928C (enExample) |
| AU (2) | AU2001241973B2 (enExample) |
| BR (1) | BR0108507A (enExample) |
| CA (1) | CA2402299C (enExample) |
| IL (2) | IL151270A0 (enExample) |
| IS (1) | IS6515A (enExample) |
| MX (1) | MXPA02008698A (enExample) |
| NO (1) | NO335780B1 (enExample) |
| NZ (1) | NZ520701A (enExample) |
| WO (1) | WO2001066697A2 (enExample) |
Families Citing this family (152)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7410798B2 (en) * | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
| US7413904B2 (en) * | 1998-10-23 | 2008-08-19 | Geron Corporation | Human embryonic stem cells having genetic modifications |
| US10638734B2 (en) | 2004-01-05 | 2020-05-05 | Abt Holding Company | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| US8252280B1 (en) | 1999-08-05 | 2012-08-28 | Regents Of The University Of Minnesota | MAPC generation of muscle |
| US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
| US7455983B2 (en) * | 2000-01-11 | 2008-11-25 | Geron Corporation | Medium for growing human embryonic stem cells |
| US20100173410A1 (en) * | 2000-03-09 | 2010-07-08 | Wicell Research Institute, Inc. | Cultivation of Primate Embryonic Stem Cells |
| US7514260B2 (en) * | 2004-05-21 | 2009-04-07 | Wicell Research Institute, Inc. | Feeder independent extended culture of embryonic stem cells |
| US7439064B2 (en) * | 2000-03-09 | 2008-10-21 | Wicell Research Institute, Inc. | Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium |
| JP2004529621A (ja) | 2001-02-14 | 2004-09-30 | ティー ファークト,レオ | 多能性成体幹細胞、その起源、それを得る方法および維持する方法、それを分化させる方法、その使用法、ならびにそれ由来の細胞 |
| AU2002354893A1 (en) * | 2001-07-20 | 2003-03-03 | Technion Research And Development Foundation Ltd. | Methods of generating human cardiac cells and tissues and uses thereof |
| AU2002364506A1 (en) * | 2001-11-09 | 2003-06-10 | Trustees Of The University Of Pennsylvania | Compositions for the derivation of germ cells from stem cells and methods of use thereof |
| GB0202149D0 (en) | 2002-01-30 | 2002-03-20 | Univ Edinburgh | Pluripotency determining factors and uses thereof |
| US20040111285A1 (en) * | 2002-04-09 | 2004-06-10 | Mark Germain | Method for human pluripotent stem cells |
| AU2003260724A1 (en) * | 2002-08-22 | 2004-03-11 | Celltran Limited | Cell culture surface |
| WO2004038012A1 (en) * | 2002-10-25 | 2004-05-06 | Hunan Hui-Lin Life Technology Co. Ltd | The feeder cell layer for in vitro culturing human embryonic stem cells and the method for culturing embryonic stem cells |
| GB0304918D0 (en) * | 2003-03-05 | 2003-04-09 | Celltran Ltd | Cell culture |
| US7820439B2 (en) | 2003-09-03 | 2010-10-26 | Reliance Life Sciences Pvt Ltd. | In vitro generation of GABAergic neurons from pluripotent stem cells |
| US20070269412A1 (en) * | 2003-12-02 | 2007-11-22 | Celavie Biosciences, Llc | Pluripotent cells |
| ES2579804T3 (es) | 2003-12-02 | 2016-08-16 | Celavie Biosciences, Llc | Composiciones y métodos para la propagación de células progenitoras neurales |
| US7625753B2 (en) * | 2003-12-23 | 2009-12-01 | Cythera, Inc. | Expansion of definitive endoderm cells |
| US7985585B2 (en) | 2004-07-09 | 2011-07-26 | Viacyte, Inc. | Preprimitive streak and mesendoderm cells |
| CN103898045B (zh) | 2003-12-23 | 2019-02-01 | 维亚希特公司 | 定形内胚层 |
| US7541185B2 (en) * | 2003-12-23 | 2009-06-02 | Cythera, Inc. | Methods for identifying factors for differentiating definitive endoderm |
| WO2007059007A2 (en) | 2005-11-14 | 2007-05-24 | Cythera, Inc. | Markers of definitive endoderm |
| US20050266554A1 (en) * | 2004-04-27 | 2005-12-01 | D Amour Kevin A | PDX1 expressing endoderm |
| US8647873B2 (en) | 2004-04-27 | 2014-02-11 | Viacyte, Inc. | PDX1 expressing endoderm |
| US20050233446A1 (en) * | 2003-12-31 | 2005-10-20 | Parsons Xuejun H | Defined media for stem cell culture |
| CN1914313A (zh) * | 2004-02-13 | 2007-02-14 | 旭科技玻璃股份有限公司 | 胚胎干细胞用喂食细胞培育培养基及喂食细胞 |
| AU2005224569B2 (en) | 2004-03-23 | 2011-07-14 | Toshihiro Akaike | Method of proliferating pluripotent stem cell |
| EP2377922B1 (en) | 2004-04-27 | 2020-04-08 | Viacyte, Inc. | PDX1 expressing endoderm |
| CA2573354C (en) | 2004-07-09 | 2015-02-24 | Cythera, Inc. | Preprimitive streak and mesendoderm cells |
| US8187878B2 (en) * | 2004-08-13 | 2012-05-29 | University Of Georgia Research Foundation, Inc. | Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors |
| ES2383813T3 (es) * | 2004-09-08 | 2012-06-26 | Wisconsin Alumni Research Foundation | Método de cultivo y cultivo de células madre embrionarias |
| ES2800973T3 (es) * | 2004-09-28 | 2021-01-07 | Wisconsin Alumni Res Found | Cultivo de células madre embrionarias de primates |
| US8017395B2 (en) | 2004-12-17 | 2011-09-13 | Lifescan, Inc. | Seeding cells on porous supports |
| US20060275899A1 (en) * | 2004-12-30 | 2006-12-07 | Stemlifeline, Inc. | Methods and compositions relating to embryonic stem cell lines |
| EP1844139A1 (en) * | 2004-12-30 | 2007-10-17 | Stemlifeline, Inc. | Methods and systems relating to embryonic stem cell lines |
| CN1298843C (zh) * | 2005-02-07 | 2007-02-07 | 十堰市太和医院 | 不依赖饲养细胞的人胚干细胞培养基 |
| AU2006202209B2 (en) * | 2005-05-27 | 2011-04-14 | Lifescan, Inc. | Amniotic fluid derived cells |
| AU2006255183B2 (en) * | 2005-06-08 | 2012-02-02 | Centocor, Inc. | A cellular therapy for ocular degeneration |
| CN101233226B (zh) * | 2005-06-22 | 2017-08-11 | 阿斯特利亚斯生物治疗股份公司 | 人胚胎干细胞的悬浮培养物 |
| WO2007016366A2 (en) * | 2005-07-29 | 2007-02-08 | Yale University | Defined culture conditions of human embryonic stem cells |
| KR100670616B1 (ko) * | 2005-08-25 | 2007-01-17 | 주식회사 메디아나전자 | 상피세포 또는 섬유아세포를 이용한 세포 배양용 인공 배아 및 세포 배양 장치 |
| EP1943334A1 (en) * | 2005-09-02 | 2008-07-16 | Agency for Science, Technology and Research | Method of deriving progenitor cell line |
| CA2625078A1 (en) * | 2005-10-06 | 2007-04-19 | University Of Massachusetts | Cell division marker |
| CA2624728A1 (en) * | 2005-10-07 | 2007-04-19 | Cellartis Ab | A method for obtaining a xeno-free hbs cell line |
| EP3584311A1 (en) | 2005-10-27 | 2019-12-25 | Viacyte, Inc. | Pdx-1 expressing dorsal and ventral foregut endoderm |
| US7413900B2 (en) * | 2005-10-31 | 2008-08-19 | President And Fellows Of Harvard College | Immortalized fibroblasts |
| US7695965B2 (en) | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
| US11254916B2 (en) | 2006-03-02 | 2022-02-22 | Viacyte, Inc. | Methods of making and using PDX1-positive pancreatic endoderm cells |
| EP2650359B1 (en) | 2006-03-02 | 2022-05-04 | Viacyte, Inc. | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
| EP4438720A3 (en) | 2006-04-28 | 2025-02-26 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| US7989204B2 (en) | 2006-04-28 | 2011-08-02 | Viacyte, Inc. | Hepatocyte lineage cells |
| US8741643B2 (en) | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
| CN100465268C (zh) * | 2006-05-17 | 2009-03-04 | 北京大学 | 人胚胎干细胞的培养方法及其专用培养基 |
| WO2007139929A2 (en) * | 2006-05-25 | 2007-12-06 | The Burnham Institute For Medical Research | Methods for culture and production of single cell populations of human embryonic stem cells |
| EP2032689A1 (en) * | 2006-06-20 | 2009-03-11 | Genzyme Corporation | Serum-free media and their uses for chondrocyte expansion |
| WO2008018684A1 (en) * | 2006-08-11 | 2008-02-14 | Modern Cell & Tissue Technologies Inc. | Culture medium for co-culturing of human stem cells and their feeder cells |
| WO2008048647A1 (en) * | 2006-10-17 | 2008-04-24 | Cythera, Inc. | Modulation of the phosphatidylinositol-3-kinase pathway in the differentiation of human embryonic stem cells |
| US9005964B2 (en) | 2006-11-24 | 2015-04-14 | Regents Of The University Of Minnesota | Endodermal progenitor cells |
| US10829733B2 (en) * | 2007-01-04 | 2020-11-10 | Biolamina Ab | Composition and method for enabling proliferation of pluripotent human stem cells |
| US7883698B2 (en) * | 2007-01-17 | 2011-02-08 | Maria Michejda | Isolation and preservation of fetal hematopoietic and mesencymal system cells from non-controversial materials and/or tissues resulting from miscarriages and methods of therapeutic use |
| AU2008211103B2 (en) * | 2007-01-30 | 2014-05-08 | University Of Georgia Research Foundation, Inc. | Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (MMC) |
| EP1972685B1 (en) * | 2007-03-20 | 2015-09-02 | Université Paris Descartes | Culture medium for gingival fibroblasts |
| MX2010000348A (es) | 2007-07-01 | 2010-04-12 | Lifescan Inc | Cultivo de celulas madre pluripotentes individuales. |
| US9080145B2 (en) * | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
| ES2537578T3 (es) | 2007-07-18 | 2015-06-09 | Lifescan, Inc. | Diferenciación de las células madre de embriones humanos |
| CA2695225C (en) | 2007-07-31 | 2021-06-01 | Lifescan, Inc. | Differentiation of human embryonic stem cells to pancreatic endocrine |
| BRPI0815052A2 (pt) | 2007-07-31 | 2014-10-21 | Lifescan Inc | Diferenciação de células-tronco pluripotentes por meio de uso de células nutrizes humanas |
| US7695963B2 (en) | 2007-09-24 | 2010-04-13 | Cythera, Inc. | Methods for increasing definitive endoderm production |
| US9062290B2 (en) | 2007-11-27 | 2015-06-23 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
| US20100087002A1 (en) * | 2008-02-21 | 2010-04-08 | Benjamin Fryer | Methods, Surface Modified Plates and Compositions for Cell Attachment, Cultivation and Detachment |
| BRPI0908033A2 (pt) | 2008-02-21 | 2015-08-04 | Centocor Ortho Biotech Inc | Método placas de superfície modificada e composições para adesão, cultura e desprendimento de célula |
| US8338170B2 (en) | 2008-04-21 | 2012-12-25 | Viacyte, Inc. | Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells |
| DK2283117T3 (da) | 2008-04-21 | 2014-01-20 | Viacyte Inc | Fremgangsmåde til oprensning af pancreatiske endodermceller afledt fra humane embryoniske stamceller |
| US7939322B2 (en) | 2008-04-24 | 2011-05-10 | Centocor Ortho Biotech Inc. | Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm |
| US8623648B2 (en) * | 2008-04-24 | 2014-01-07 | Janssen Biotech, Inc. | Treatment of pluripotent cells |
| KR101598867B1 (ko) | 2008-04-30 | 2016-03-03 | 산바이오 인코포레이티드 | Dna 메틸화에 변형을 가진 신경 재생 세포 |
| US20090298178A1 (en) * | 2008-06-03 | 2009-12-03 | D Amour Kevin Allen | Growth factors for production of definitive endoderm |
| DK2297319T3 (en) | 2008-06-03 | 2015-10-19 | Viacyte Inc | GROWTH FACTORS FOR PREPARING DEFINITIVE ENDODERM |
| MX2011000123A (es) * | 2008-06-30 | 2011-02-25 | Centocor Ortho Biotech Inc | Diferenciacion de las celulas madre pluripotentes. |
| BRPI0914116A2 (pt) | 2008-06-30 | 2019-09-17 | Centocor Ortho Biotech Inc | diferenciação de células-tronco pluripotentes |
| US20110305672A1 (en) | 2008-07-25 | 2011-12-15 | University Of Georgia Research Foundation, Inc. | COMPOSITIONS FOR MESODERM DERIVED ISL1+ MULTIPOTENT CELLS (IMPs), EPICARDIAL PROGENITOR CELLS (EPCs) AND MULTIPOTENT CD56C CELLS (C56Cs) AND METHODS OF PRODUCING AND USING SAME |
| WO2010011352A2 (en) | 2008-07-25 | 2010-01-28 | The University Of Georgia Research Foundation, Inc. | Compositions for mesoderm derived isl1+ multipotent cells (imps), epicardial progenitor cells (epcs) and multipotent cxcr4+cd56+ cells (c56cs) and methods of use |
| US20100028307A1 (en) * | 2008-07-31 | 2010-02-04 | O'neil John J | Pluripotent stem cell differentiation |
| EP2346988B1 (en) * | 2008-10-31 | 2017-05-31 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
| BRPI0919883A2 (pt) * | 2008-10-31 | 2015-08-11 | Centocor Ortho Biotech Inc | Diferenciação de células-tronco embrionárias humanas para a linhagem endócrina pancreática |
| IL289685B2 (en) | 2008-11-04 | 2025-09-01 | Viacyte Inc | Stem cell pool suspension preparations and methods for their differentiation |
| CN105349517B (zh) | 2008-11-14 | 2021-05-04 | 维赛特公司 | 源于人多能干细胞的胰腺细胞的包封 |
| ES2642070T3 (es) | 2008-11-20 | 2017-11-15 | Janssen Biotech, Inc. | Cultivo de células madre pluripotentes en microportadores |
| CN102257132B (zh) * | 2008-11-20 | 2014-09-03 | 森托科尔奥索生物科技公司 | 用于在平面基底上进行细胞附着和培养的方法和组合物 |
| US20100209399A1 (en) * | 2009-02-13 | 2010-08-19 | Celavie Biosciences, Llc | Brain-derived stem cells for repair of musculoskeletal system in vertebrate subjects |
| WO2010096496A2 (en) | 2009-02-17 | 2010-08-26 | Memorial Sloan-Kettering Cancer Center | Methods of neural conversion of human embryonic stem cells |
| US9109245B2 (en) | 2009-04-22 | 2015-08-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
| DK2421957T3 (da) | 2009-04-22 | 2021-01-25 | Viacyte Inc | Cellesammensætninger afledt af dedifferentierede omprogrammerede celler |
| AU2010276440B2 (en) | 2009-07-20 | 2014-07-03 | Janssen Biotech Inc. | Differentiation of human embryonic stem cells |
| AU2010276402B2 (en) | 2009-07-20 | 2014-07-03 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| BR112012001480A2 (pt) | 2009-07-20 | 2015-09-01 | Janssen Biotech Inc | Diferenciação de células-tronco embriônicas humanas |
| EP2462230B1 (en) | 2009-08-03 | 2015-07-15 | Recombinetics, Inc. | Methods and compositions for targeted gene modification |
| JP5957382B2 (ja) * | 2009-10-29 | 2016-07-27 | ヤンセン バイオテツク,インコーポレーテツド | 多能性幹細胞 |
| WO2011063005A2 (en) | 2009-11-17 | 2011-05-26 | Advanced Cell Technology, Inc. | Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells |
| EP2516626B1 (en) * | 2009-12-23 | 2017-05-10 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| WO2011079017A2 (en) | 2009-12-23 | 2011-06-30 | Centocor Ortho Biotech Inc. | Differentiation of human embryonic stem cells |
| WO2011109279A2 (en) | 2010-03-01 | 2011-09-09 | Centocor Ortho Biotech Inc. | Methods for purifying cells derived from pluripotent stem cells |
| EP3498825A1 (en) | 2010-05-12 | 2019-06-19 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| EP3549617B1 (en) | 2010-07-12 | 2023-09-13 | University of Southern California | Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same |
| DK2603226T3 (da) | 2010-08-12 | 2021-06-07 | Janssen Biotech Inc | Behandling af diabetes med endokrine pankreas-prækursorceller |
| RU2673946C1 (ru) | 2010-08-31 | 2018-12-03 | Янссен Байотек, Инк. | Дифференцирование плюрипотентных стволовых клеток |
| US9506036B2 (en) | 2010-08-31 | 2016-11-29 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| ES2659393T3 (es) | 2010-08-31 | 2018-03-15 | Janssen Biotech, Inc. | Diferenciación de células madre embrionarias humanas |
| EP2630232A4 (en) | 2010-10-22 | 2014-04-02 | Biotime Inc | METHOD FOR MODIFYING TRANSCRIPTIONAL REGULATORY NETWORKS IN STEM CELLS |
| EP2651973B1 (en) * | 2010-12-17 | 2016-08-31 | Biolamina AB | Recombinant laminin-521 |
| US9700596B2 (en) | 2011-03-04 | 2017-07-11 | The Regents Of The University Of California | Locally released growth factors to mediate motor recovery after stroke |
| US8785190B2 (en) | 2011-04-06 | 2014-07-22 | Sanbio, Inc. | Methods and compositions for modulating peripheral immune function |
| WO2012149468A2 (en) | 2011-04-29 | 2012-11-01 | University Of Southern California | Instruments and methods for the implantation of cell-seeded substrates |
| US8877489B2 (en) | 2011-12-05 | 2014-11-04 | California Institute Of Technology | Ultrathin parylene-C semipermeable membranes for biomedical applications |
| WO2012170853A1 (en) | 2011-06-10 | 2012-12-13 | Wisconsin Alumni Research Foundation ("Warf") | Methods and devices for differentiating pluripotent stem cells into cells of the pancreatic lineage |
| WO2013010045A1 (en) | 2011-07-12 | 2013-01-17 | Biotime Inc. | Novel methods and formulations for orthopedic cell therapy |
| BR122020000182B8 (pt) | 2011-11-04 | 2022-05-24 | Memorial Sloan Kettering Cancer Center | Neurônios dopaminérgicos do mesencéfalo para enxerto |
| US9248013B2 (en) | 2011-12-05 | 2016-02-02 | California Institute Of Technology | 3-Dimensional parylene scaffold cage |
| EP2794857A4 (en) | 2011-12-22 | 2015-07-08 | Janssen Biotech Inc | DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS IN SINGLE INSULIN POSITIVE CELLS |
| HK1206058A1 (en) | 2012-03-07 | 2015-12-31 | Janssen Biotech, Inc. | Defined media for expansion and maintenance of pluripotent stem cells |
| BR112014028881A2 (pt) | 2012-05-23 | 2017-06-27 | Hoffmann La Roche | populações de células, banco de células, métodos de obtenção de uma população de células, métodos de identificação de um fator, métodos de seleção, métodos de fornecimento de terapia, populações de hepatócitos e método de obtenção de células |
| ES2897649T3 (es) | 2012-06-08 | 2022-03-02 | Janssen Biotech Inc | Diferenciación de células madre embrionarias humanas en células endocrinas pancreáticas |
| CN102732477B (zh) * | 2012-06-15 | 2013-06-19 | 江苏瑞思坦生物科技有限公司 | 人脂肪干细胞无血清基础培养基 |
| SG11201500799YA (en) | 2012-07-31 | 2015-03-30 | Basil M Hantash | Hla g-modified cells and methods |
| AU2013237760A1 (en) | 2012-10-08 | 2014-04-24 | Biotime, Inc. | Differentiated progeny of clonal progenitor cell lines |
| AU2013248265B2 (en) | 2012-11-08 | 2018-11-01 | Viacyte, Inc. | Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof |
| US10370644B2 (en) | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
| RU2687379C2 (ru) | 2012-12-31 | 2019-05-13 | Янссен Байотек, Инк. | Суспендирование и кластеризация плюрипотентных клеток человека с целью их дифференцировки в панкреатические эндокринные клетки |
| AU2013368221B2 (en) | 2012-12-31 | 2018-11-01 | Janssen Biotech, Inc. | Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells |
| EP4219683A1 (en) | 2012-12-31 | 2023-08-02 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators |
| US8859286B2 (en) | 2013-03-14 | 2014-10-14 | Viacyte, Inc. | In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells |
| WO2014176606A1 (en) | 2013-04-26 | 2014-10-30 | Memorial Sloan-Kettering Center Center | Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells |
| EP3888640B1 (en) | 2013-06-05 | 2025-09-17 | Reverse Bioengineering, Inc. | Compositions and methods for induced tissue regeneration in mammalian species |
| BR112015031094A2 (pt) | 2013-06-14 | 2017-07-25 | Univ Queensland | células progenitoras renais |
| EP3071685A4 (en) | 2013-11-21 | 2017-07-05 | Memorial Sloan Kettering Cancer Center | Specification of functional cranial placode derivatives from human pluripotent stem cells |
| US11078462B2 (en) | 2014-02-18 | 2021-08-03 | ReCyte Therapeutics, Inc. | Perivascular stromal cells from primate pluripotent stem cells |
| CA2949056C (en) | 2014-05-16 | 2025-10-07 | Janssen Biotech, Inc. | USE OF SMALL MOLECULES TO IMPROVE MAFA GENE EXPRESSION IN PANCREATIC ENDOCRINE CELLS |
| US20170114323A1 (en) | 2014-06-19 | 2017-04-27 | Whitehead Institute For Biomedical Research | Uses of kinase inhibitors for inducing and maintaining pluripotency |
| US10240127B2 (en) | 2014-07-03 | 2019-03-26 | ReCyte Therapeutics, Inc. | Exosomes from clonal progenitor cells |
| CN104357379B (zh) * | 2014-09-30 | 2017-08-08 | 刘兴宇 | 干细胞培养基 |
| CA3202332A1 (en) | 2015-12-07 | 2017-06-15 | Agex Therapeutics, Inc. | Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells |
| EP3423158B1 (en) | 2016-02-24 | 2023-11-15 | The Rockefeller University | Embryonic cell-based therapeutic candidate screening systems, models for huntington's disease and uses thereof |
| MA45479A (fr) | 2016-04-14 | 2019-02-20 | Janssen Biotech Inc | Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen |
| KR101877793B1 (ko) * | 2016-07-15 | 2018-07-13 | 주식회사 엔바이오텍 | 줄기세포 배양용 무혈청 배지 조성물 및 이를 이용한 줄기세포의 배양 방법 |
| US11268950B2 (en) | 2016-09-28 | 2022-03-08 | Organovo, Inc. | Use of engineered renal tissues in assays |
| CN106754652B (zh) * | 2017-03-06 | 2019-04-02 | 广州润虹医药科技股份有限公司 | iPS细胞分化成外胚层祖细胞的无血清诱导培养基及诱导方法 |
| CN106754657B (zh) * | 2017-03-28 | 2022-07-22 | 北京赛斯达生物技术有限公司 | 一种猴胚胎干细胞的无血清培养基 |
| US20210123016A1 (en) | 2018-05-02 | 2021-04-29 | Novartis Ag | Regulators of human pluripotent stem cells and uses thereof |
| CN114109294A (zh) * | 2020-08-26 | 2022-03-01 | 中石化胜利石油工程有限公司管具技术服务中心 | 闸板拆装装置及其控制系统 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5405772A (en) * | 1993-06-18 | 1995-04-11 | Amgen Inc. | Medium for long-term proliferation and development of cells |
| US5750376A (en) * | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
| WO1998030679A1 (en) * | 1997-01-10 | 1998-07-16 | Life Technologies, Inc. | Embryonic stem cell serum replacement |
| WO1999020740A2 (en) * | 1997-10-23 | 1999-04-29 | Geron Corporation | Methods and materials for the growth of primate-derived primordial stem cells |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US670372A (en) * | 1898-01-13 | 1901-03-19 | William D Carpenter | Process of producing casein products. |
| US5612211A (en) | 1990-06-08 | 1997-03-18 | New York University | Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
| IL106327A (en) * | 1992-07-21 | 1997-06-10 | Perini Fabio Spa | Machine and method for the formation of coreless rolls of web material |
| US5453357A (en) | 1992-10-08 | 1995-09-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
| US5690926A (en) | 1992-10-08 | 1997-11-25 | Vanderbilt University | Pluripotential embryonic cells and methods of making same |
| US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| AU3392697A (en) | 1996-06-14 | 1998-01-07 | Regents Of The University Of California, The | (in vitro) derivation and culture of primate pluripotent stem cells and therapeutic uses thereof |
| US6331406B1 (en) * | 1997-03-31 | 2001-12-18 | The John Hopkins University School Of Medicine | Human enbryonic germ cell and methods of use |
| GB9722370D0 (en) * | 1997-10-22 | 1997-12-17 | Ici Plc | Dye sheet cassette and printing apparatus |
| DE19756864C5 (de) | 1997-12-19 | 2014-07-10 | Oliver Brüstle | Neurale Vorläuferzellen, Verfahren zu ihrer Herstellung und ihre Verwendung zur Therapie von neuralen Defekten |
| US7410798B2 (en) * | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
| US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
| ATE319811T1 (de) | 1999-05-07 | 2006-03-15 | Univ Utah Res Found | Auf eine zellinie beschränkte vorläuferzellen aus dem neuralrohr der maus und aus embryonalen stammzellen der maus |
| IL129966A (en) * | 1999-05-14 | 2009-12-24 | Technion Res & Dev Foundation | ISOLATED HUMAN EMBRYOID BODIES (hEB) DERIVED FROM HUMAN EMBRYONIC STEM CELLS |
| US6750581B2 (en) * | 2002-01-24 | 2004-06-15 | Visteon Global Technologies, Inc. | Automotive alternator stator assembly with rectangular continuous wire |
-
2000
- 2000-03-09 US US09/522,030 patent/US7005252B1/en not_active Expired - Lifetime
-
2001
- 2001-03-02 IL IL15127001A patent/IL151270A0/xx unknown
- 2001-03-02 AU AU2001241973A patent/AU2001241973B2/en not_active Expired
- 2001-03-02 EP EP01913296.8A patent/EP1261691B1/en not_active Expired - Lifetime
- 2001-03-02 CN CNB018062350A patent/CN100372928C/zh not_active Expired - Lifetime
- 2001-03-02 NZ NZ520701A patent/NZ520701A/en not_active IP Right Cessation
- 2001-03-02 MX MXPA02008698A patent/MXPA02008698A/es active IP Right Grant
- 2001-03-02 KR KR1020027011681A patent/KR100795760B1/ko not_active Expired - Lifetime
- 2001-03-02 AU AU4197301A patent/AU4197301A/xx active Pending
- 2001-03-02 JP JP2001565854A patent/JP5717311B2/ja not_active Expired - Lifetime
- 2001-03-02 BR BR0108507-7A patent/BR0108507A/pt not_active Application Discontinuation
- 2001-03-02 CA CA2402299A patent/CA2402299C/en not_active Expired - Lifetime
- 2001-03-02 WO PCT/US2001/006912 patent/WO2001066697A2/en not_active Ceased
-
2002
- 2002-08-14 IL IL151270A patent/IL151270A/en unknown
- 2002-08-20 IS IS6515A patent/IS6515A/is unknown
- 2002-09-03 NO NO20024200A patent/NO335780B1/no not_active IP Right Cessation
-
2003
- 2003-05-06 US US10/430,497 patent/US7217569B2/en not_active Expired - Lifetime
-
2004
- 2004-09-28 US US10/952,096 patent/US20050148070A1/en not_active Abandoned
-
2005
- 2005-10-25 US US11/257,704 patent/US20060040384A1/en not_active Abandoned
-
2011
- 2011-07-27 JP JP2011164419A patent/JP5839666B2/ja not_active Expired - Lifetime
- 2011-07-27 JP JP2011164743A patent/JP2011234735A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750376A (en) * | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
| US5405772A (en) * | 1993-06-18 | 1995-04-11 | Amgen Inc. | Medium for long-term proliferation and development of cells |
| WO1998030679A1 (en) * | 1997-01-10 | 1998-07-16 | Life Technologies, Inc. | Embryonic stem cell serum replacement |
| WO1999020740A2 (en) * | 1997-10-23 | 1999-04-29 | Geron Corporation | Methods and materials for the growth of primate-derived primordial stem cells |
Non-Patent Citations (1)
| Title |
|---|
| Biochemical and Biophysical Research communications Vol.191(1):188-195 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001241973B2 (en) | 2006-11-09 |
| NO20024200L (no) | 2002-09-03 |
| BR0108507A (pt) | 2002-12-17 |
| US7005252B1 (en) | 2006-02-28 |
| JP5839666B2 (ja) | 2016-01-06 |
| EP1261691B1 (en) | 2013-07-31 |
| HK1053616A1 (zh) | 2003-10-31 |
| WO2001066697A2 (en) | 2001-09-13 |
| CN1416345A (zh) | 2003-05-07 |
| NZ520701A (en) | 2004-03-26 |
| MXPA02008698A (es) | 2003-04-14 |
| CA2402299A1 (en) | 2001-09-13 |
| IS6515A (is) | 2002-08-20 |
| NO335780B1 (no) | 2015-02-16 |
| KR20030032926A (ko) | 2003-04-26 |
| US7217569B2 (en) | 2007-05-15 |
| CN100372928C (zh) | 2008-03-05 |
| IL151270A0 (en) | 2003-04-10 |
| US20060040384A1 (en) | 2006-02-23 |
| JP2012005489A (ja) | 2012-01-12 |
| CA2402299C (en) | 2012-12-18 |
| US20050148070A1 (en) | 2005-07-07 |
| JP2003525625A (ja) | 2003-09-02 |
| EP1261691A2 (en) | 2002-12-04 |
| IL151270A (en) | 2008-07-08 |
| US20030190748A1 (en) | 2003-10-09 |
| AU4197301A (en) | 2001-09-17 |
| WO2001066697A3 (en) | 2002-03-07 |
| NO20024200D0 (no) | 2002-09-03 |
| JP5717311B2 (ja) | 2015-05-13 |
| JP2011234735A (ja) | 2011-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100795760B1 (ko) | 영장류 배아 줄기 세포의 무혈청 배양 | |
| AU2001241973A1 (en) | Serum free cultivation of primate embryonic stem cells | |
| KR101437927B1 (ko) | 영장류 배아 줄기 세포의 배양 | |
| US20120178160A1 (en) | Cultivation Of Primate Embryonic Stem Cells | |
| US7413904B2 (en) | Human embryonic stem cells having genetic modifications | |
| AU2007200575B2 (en) | Serum free cultivation of primate embryonic stem cells | |
| HK1053616B (en) | Serum free cultivation of primate embryonic stem cells | |
| JP6314193B2 (ja) | 霊長類胚性幹細胞の培養 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20020906 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| AMND | Amendment | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20060228 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20061205 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20070713 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20061205 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| AMND | Amendment | ||
| J201 | Request for trial against refusal decision | ||
| PJ0201 | Trial against decision of rejection |
Patent event date: 20071015 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 20070713 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20071214 Appeal identifier: 2007101010771 Request date: 20071015 |
|
| PB0901 | Examination by re-examination before a trial |
Comment text: Amendment to Specification, etc. Patent event date: 20071015 Patent event code: PB09011R02I Comment text: Request for Trial against Decision on Refusal Patent event date: 20071015 Patent event code: PB09011R01I Comment text: Amendment to Specification, etc. Patent event date: 20060228 Patent event code: PB09011R02I |
|
| B701 | Decision to grant | ||
| PB0701 | Decision of registration after re-examination before a trial |
Patent event date: 20071214 Comment text: Decision to Grant Registration Patent event code: PB07012S01D Patent event date: 20071115 Comment text: Transfer of Trial File for Re-examination before a Trial Patent event code: PB07011S01I |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20080111 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20080114 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| G170 | Re-publication after modification of scope of protection [patent] | ||
| PG1701 | Publication of correction | ||
| PR1001 | Payment of annual fee |
Payment date: 20101222 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20111226 Start annual number: 5 End annual number: 5 |
|
| FPAY | Annual fee payment |
Payment date: 20121226 Year of fee payment: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20121226 Start annual number: 6 End annual number: 6 |
|
| FPAY | Annual fee payment |
Payment date: 20131220 Year of fee payment: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20131220 Start annual number: 7 End annual number: 7 |
|
| FPAY | Annual fee payment |
Payment date: 20141231 Year of fee payment: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20141231 Start annual number: 8 End annual number: 8 |
|
| FPAY | Annual fee payment |
Payment date: 20151217 Year of fee payment: 9 |
|
| PR1001 | Payment of annual fee |
Payment date: 20151217 Start annual number: 9 End annual number: 9 |
|
| FPAY | Annual fee payment |
Payment date: 20161220 Year of fee payment: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 20161220 Start annual number: 10 End annual number: 10 |
|
| FPAY | Annual fee payment |
Payment date: 20171219 Year of fee payment: 11 |
|
| PR1001 | Payment of annual fee |
Payment date: 20171219 Start annual number: 11 End annual number: 11 |
|
| FPAY | Annual fee payment |
Payment date: 20181226 Year of fee payment: 12 |
|
| PR1001 | Payment of annual fee |
Payment date: 20181226 Start annual number: 12 End annual number: 12 |
|
| FPAY | Annual fee payment |
Payment date: 20191217 Year of fee payment: 13 |
|
| PR1001 | Payment of annual fee |
Payment date: 20191217 Start annual number: 13 End annual number: 13 |
|
| PR1001 | Payment of annual fee |
Payment date: 20201216 Start annual number: 14 End annual number: 14 |
|
| PC1801 | Expiration of term |
Termination date: 20210902 Termination category: Expiration of duration |